Related Experiment Videos
Autologous osteochondral grafting for talar cartilage defects
Raad A Al-Shaikh1, Loretta B Chou, Jeffrey A Mann
1Division of Orthopaedic Surgery, Stanford University Medical Center, CA 94305, USA.
Foot & Ankle International
|June 5, 2002
Summary
Osteochondral autograft transfer (OATS) effectively treats talar osteochondral defects, improving ankle function and reducing pain. This procedure shows excellent results, even for patients with prior failed treatments.
Area of Science:
- Orthopedic Surgery
- Sports Medicine
- Regenerative Medicine
Background:
- Symptomatic osteochondral defects (OCD) of the talus often present challenges in treatment, with many patients failing conservative management.
- Previous surgical interventions like excision, curettage, or drilling may not yield satisfactory long-term outcomes for talar OCDs.
Observation:
- This study evaluated the clinical outcomes of the Osteochondral Autograft Transfer System (OATS) in 19 patients with symptomatic talar OCDs.
- Patients undergoing OATS had an average lesion size of 12x10 mm, with donor plugs harvested from the femoral condyle.
- The average follow-up was 16 months, with clinical assessments using the AOFAS Ankle/Hindfoot Scale and Lysholm knee scale.
Findings:
- Postoperative AOFAS ankle scores averaged 88, indicating significant improvement in pain, function, range of motion, stability, and alignment.
- Patients who had failed prior surgeries demonstrated excellent outcomes, with an average AOFAS score of 91.
- Donor knee sites showed minimal morbidity, with an average Lysholm knee score of 97, and 17 out of 19 patients would recommend the procedure.
Implications:
- OATS is a viable and effective treatment for talar osteochondral defects, offering substantial clinical improvement.
- The procedure serves as an effective salvage option for patients with recalcitrant symptoms or those who have undergone previous unsuccessful treatments.
- Autologous osteochondral grafting provides a reliable solution for talar OCDs with low donor site morbidity and high patient satisfaction.